Join
Live feed
·
PRReleasevia Quantisnow
LAVA Therapeutics N.V. logo
XOMA Royalty Corporation logo

XOMA Royalty and LAVA Therapeutics Announce Amendment to Purchase Agreement

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LVTX (LAVA Therapeutics N.V.), XOMA (XOMA Royalty Corporation) and more on Quantisnow.